Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Enhanced liver markers indicate reduced risk of fatty liver disease, which frequently accompanies obesity and metabolic syndrome
The risk of insulin sensitivity changes increases with prolonged high-dose use
Staying hydrated matters more on GLP-1 medications
The primary outcome is simple but meaningful: How many heavy drinking days per week they have at the end of the study compared to when they started. Secondary outcomes include changes in WHO risk categories and levels of phosphatidylethanol, a blood biomarker for alcohol use
However, it also have potential side effects which must be considered
US$ 28.13
US$ 22.46
US$ 25.72
US$ 26.08
US$ 21.34
US$ 24.93
US$ 23.42
US$ 25.28
